发明名称 |
Compositions and methods of therapy for igf-i-responsive conditions |
摘要 |
Compositions and methods useful in therapy for IGF-I-responsive conditions in a mammal are provided. The method comprises concurrent therapy with both IGF-I or a variant thereof and at least one GAG to promote a desired therapeutic response with respect to a particular IGF-I- responsive condition. Concurrent therapy is achieved by admininstering to a mammal a single pharmaceutical composition containing both IGF-I (or a variant thereof) and at least one GAG according to a dosing regimen. Alternatively, IGF-I or a variant thereof and at least one GAG can be administered as two separate pharmaceutical compositions. A pharmaceutical composition comprising IGF-I or a variant thereof and at least one GAG for use in the IGF-I and GAG therapy is also provided. |
申请公布号 |
AU7370798(A) |
申请公布日期 |
1998.11.27 |
申请号 |
AU19980073707 |
申请日期 |
1998.05.06 |
申请人 |
CHIRON CORPORATION;BRUCE F SCHARSCHMIDT;ALFREDO GORIO;EUGENIO E. MULLER |
发明人 |
BRUCE F SCHARSCHMIDT;ALFREDO GORIO;EUGENIO E. MULLER |
分类号 |
A61K38/27;A61K31/726;A61K38/30;A61P25/00;A61P25/16;A61P25/28;A61P43/00 |
主分类号 |
A61K38/27 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|